510(k) Premarket Notification K093848   
PT-Multi Calibrator   
Additional Information   
November 2010   
Page 56 of 60

# Attachment 5

# 510(k) Summary of Safety and Effectiveness PT-Multi Calibrator

DEC 2 0 2010

(a)The device name, including both the trade or proprietary name and the common or usual name and the classification name of the device.

Trade or proprietary name: Common or usual name: Classification name:

PT-Multi Calibrator   
Calibrators   
Multipurpose System for In Vitro Coagulation Studies (21CFR   
864.5425)

(b) The establishment registration number, if applicable, of the owner or operator submitting the premarket notification submission.

Establishment Registration Numbers:

Site Activity

9610806

Manufacturer:   
Siemens Healthcare Diagnostics Marburg GmbH   
Emil-von-Behring Str. 76   
35041 Marburg, Germany Distributor/Applicant:   
Siemens Healthcare Diagnostics Inc. Glasgow Site   
Bldg. 500, M.S. 514   
P.O. Box 6101   
Newark, Delaware 19714-6101

(c) The class in which the device has been put under Section 513 of the Act and, if known, its appropriate panel; or, if the owner or operator determines that the device has not been classified under such section, a statement of the determination and the basis for the person's determination that the device is not so classified.

Class: II Panel: Hematology Product Code: GGN

(d)  Action taken by the person required to register to comply with the requirements of the Act under Section 514 for performance standards.

To date, no performance standards have been finalized for this device.

(e) Device Description

PT-Multi Calibrator is a set ofcertified plasmas for ocal PT/INR calibration and/or local verification  he INR system for plasma based procedures using Siemens Dade® Innovin® or Thromborel® S reagents on Siemens BCS® Coagulation Systems.

The calibrator levels are manufactured using a combination of normal and depleted human plasma.

# ) Device Intended Use

uall/n INR system for plasma based procedures with designated Siemens thromboplastins Dade® Innovin® or Thromborel@® S on the BCS® / BCS® XP Systems.

(g) A statement indicating the device is similar to and/or different from other products of comparable type in commercial distribution, accompanied by data to support the statement. This information may include an identification of similar products, materials, design considerations, energy expected to be used or delivered by the device, and a description of the operational principles of the device.

The PT-Multi Calibrator is substantially equivalent in intended use to HemosIL INR Validate®, HemosIL ISI Calibrate, ISI web Software (K090563), Instrumentation Laboratories Co., Lexington, MA 02421.Both devi tend clirators mtrigcracy  control al ngulant hy

# (e) Suitability of this Device is supported by the data provided below

Method Comparison studies were conducted at three different sites using at least two lots of PT-Multi Calibratorand the conventional local ISPT.Precision was evaluated at thre different sites with at lst two lots of PT-Multi Calibrator. Results of the studies are summarized in the tables below.

<table><tr><td rowspan=4 colspan=1>b</td><td rowspan=1 colspan=8>BCS System</td></tr><tr><td rowspan=1 colspan=4></td><td rowspan=1 colspan=2>without extrapolation</td><td rowspan=1 colspan=2>with extrapolation(factor 1.2)</td></tr><tr><td rowspan=2 colspan=1>Local Test SystemISI /MNPT</td><td rowspan=2 colspan=1>MNPT</td><td rowspan=2 colspan=1>ISI</td><td rowspan=2 colspan=1>PT Multi Calibrator (lot #)Local INR Calibration</td><td rowspan=2 colspan=1>n</td><td rowspan=1 colspan=1>Regression Analysis</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Regression Anatysis</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=4 colspan=1>Denver</td><td rowspan=2 colspan=1>Thromborel Slot 545197</td><td rowspan=2 colspan=1>10,9</td><td rowspan=2 colspan=1>1,12</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>138</td><td rowspan=1 colspan=1>y=0.95x-0.00</td><td rowspan=1 colspan=1>139</td><td rowspan=1 colspan=1>y=0.95x-0.00</td></tr><tr><td rowspan=1 colspan=1>37592</td><td rowspan=1 colspan=1>136</td><td rowspan=1 colspan=1>y=0.92x+0.06</td><td rowspan=1 colspan=1>139</td><td rowspan=1 colspan=1>y=0.92x+0.06</td></tr><tr><td rowspan=2 colspan=1>Innovinlot 536999</td><td rowspan=2 colspan=1>8,4</td><td rowspan=2 colspan=1>0,92</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>136</td><td rowspan=1 colspan=1>y=0.97x-0.10</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>37592</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>y=0.97x-0.03</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=4 colspan=1>Munlch</td><td rowspan=2 colspan=1>Thromborel Slot 545116</td><td rowspan=2 colspan=1>11,5</td><td rowspan=2 colspan=1>1,12</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>y=0.97x -0.02</td><td rowspan=1 colspan=1>123</td><td rowspan=1 colspan=1>y=0.97x-0.02</td></tr><tr><td rowspan=1 colspan=1>37592</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>y= 0.93x +0.06</td><td rowspan=1 colspan=1>123</td><td rowspan=1 colspan=1>y=0.93x +0.05</td></tr><tr><td rowspan=2 colspan=1>Innovinot 536997</td><td rowspan=2 colspan=1>8,7</td><td rowspan=2 colspan=1>0,92</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>106</td><td rowspan=1 colspan=1>$y=1.10x-0.20</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>37592</td><td rowspan=1 colspan=1>102</td><td rowspan=1 colspan=1>y= 1.09x-0.13</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=4 colspan=1>Marburg</td><td rowspan=2 colspan=1>Thromborel Slot 545248</td><td rowspan=2 colspan=1>12,2</td><td rowspan=2 colspan=1>1,05</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>y=0.92x +0.05</td><td rowspan=1 colspan=1>122</td><td rowspan=1 colspan=1>y=0.92x +0.05</td></tr><tr><td rowspan=1 colspan=1>38585</td><td rowspan=1 colspan=1>110</td><td rowspan=1 colspan=1>y=1.02x+0.01</td><td rowspan=1 colspan=1>121</td><td rowspan=1 colspan=1>y=1.03x+0.00</td></tr><tr><td rowspan=2 colspan=1>Innovinlot 539126</td><td rowspan=2 colspan=1>8.4</td><td rowspan=2 colspan=1>0,93</td><td rowspan=1 colspan=1>37591</td><td rowspan=1 colspan=1>112</td><td rowspan=1 colspan=1>y=0.94x-0.02</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=1 colspan=1>38585</td><td rowspan=1 colspan=1>107</td><td rowspan=1 colspan=1>y=0.98x-0.02</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr><tr><td rowspan=3 colspan=1>Jafll sites</td><td rowspan=2 colspan=1>Thromborel S</td><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>−</td><td rowspan=1 colspan=1>37591, 37592,38585</td><td rowspan=1 colspan=1>738</td><td rowspan=1 colspan=1>y=0.93x+0.03</td><td rowspan=1 colspan=1>768</td><td rowspan=1 colspan=1>y=0.94x+0.03</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Innovin</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>37591, 37592,38585</td><td rowspan=1 colspan=1>693</td><td rowspan=1 colspan=1>y=0.97x-0.04</td><td rowspan=1 colspan=1>N/A</td><td rowspan=1 colspan=1>N/A</td></tr></table>

# 510(k) Premarket Notification K093848 PT-Multi Calibrator Additional Information November 2010 Page 58 of 60

20 Day ANOVA Precision Studies on the BCS System   

<table><tr><td rowspan=1 colspan=1>Denver</td><td rowspan=1 colspan=8>LocalTesilSystem</td><td rowspan=1 colspan=4>PTM0G8bra(66132591</td><td rowspan=1 colspan=4>PTM0G8bra(66132591</td><td rowspan=1 colspan=8>PTaMGRKabratOrIDP37592</td></tr><tr><td rowspan=2 colspan=1></td><td rowspan=1 colspan=3>Innovin lot 536999</td><td rowspan=1 colspan=1>199</td><td rowspan=1 colspan=4>Thromborel S lot 545197</td><td rowspan=1 colspan=4></td><td rowspan=1 colspan=4>Thromborel $lot 545197</td><td rowspan=1 colspan=3>Einnovin1ot536</td><td rowspan=1 colspan=1>9928</td><td rowspan=1 colspan=1>Throt</td><td rowspan=1 colspan=3>borel S lot 545197</td></tr><tr><td rowspan=1 colspan=1>CPP</td><td rowspan=1 colspan=2>IC2tNPP</td><td rowspan=1 colspan=1>LPRP</td><td rowspan=1 colspan=1>CPR</td><td rowspan=1 colspan=1>C2</td><td rowspan=1 colspan=2>NPPPPP</td><td rowspan=1 colspan=1>CPP</td><td rowspan=1 colspan=2>EC21 NPPPPP</td><td rowspan=1 colspan=1>PeP</td><td rowspan=1 colspan=1>CP</td><td rowspan=1 colspan=1>EC2</td><td rowspan=1 colspan=2>NPP PPP</td><td rowspan=1 colspan=2>lcRelc2:</td><td rowspan=1 colspan=1>NPP</td><td rowspan=1 colspan=1>IPPP</td><td rowspan=1 colspan=1>ICPe</td><td rowspan=1 colspan=1>EC2:</td><td rowspan=1 colspan=1>NPP</td><td rowspan=1 colspan=1>PPP</td></tr><tr><td rowspan=1 colspan=1>Mean (INR)</td><td rowspan=1 colspan=1>2:1E</td><td rowspan=1 colspan=2>13.01103</td><td rowspan=1 colspan=1>4:0</td><td rowspan=1 colspan=1>E2.45</td><td rowspan=1 colspan=1>3:7</td><td rowspan=1 colspan=1>1:00</td><td rowspan=1 colspan=1>13:61</td><td rowspan=1 colspan=1>2:01</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>$3.8</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>E10</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>72.11</td><td rowspan=1 colspan=1>29!</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3,85</td><td rowspan=1 colspan=1>2:3</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>1:0</td><td rowspan=1 colspan=1>63.5</td></tr><tr><td rowspan=1 colspan=1>Repeatability %</td><td rowspan=1 colspan=1>671</td><td rowspan=1 colspan=2>E15111:21[</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>837.</td><td rowspan=1 colspan=1>5134</td><td rowspan=1 colspan=1>121</td><td rowspan=1 colspan=1>0.97</td><td rowspan=1 colspan=1>K181</td><td rowspan=1 colspan=1>E121</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>S121</td><td rowspan=1 colspan=1>[10.9</td><td rowspan=1 colspan=1>318</td><td rowspan=1 colspan=1>131E</td><td rowspan=1 colspan=1>SA</td><td rowspan=1 colspan=1>0.81</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>51833</td><td rowspan=1 colspan=1>310</td><td rowspan=1 colspan=1>0.9</td></tr><tr><td rowspan=1 colspan=1>Within-day-CV %</td><td rowspan=1 colspan=1>$1:7</td><td rowspan=1 colspan=2>C15212</td><td rowspan=1 colspan=1>1115</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>$1:6</td><td rowspan=1 colspan=1>"1.7</td><td rowspan=1 colspan=1>8145H</td><td rowspan=1 colspan=1>418</td><td rowspan=1 colspan=2></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=2>13.7516</td><td rowspan=1 colspan=1>$1 6</td><td rowspan=1 colspan=1>21'53</td><td rowspan=1 colspan=1>1'8!</td><td rowspan=1 colspan=1>3115</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>11:51</td><td rowspan=1 colspan=1>C3:6:</td><td rowspan=1 colspan=1>X15</td><td rowspan=1 colspan=1>31'51</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Between-run-CV %</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>20.9.</td><td rowspan=1 colspan=1>M:2</td><td rowspan=1 colspan=1>1151</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>'05</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>101</td><td rowspan=1 colspan=1>31:2</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>0.9</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3OS</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>ETET</td><td rowspan=1 colspan=1>31811</td></tr><tr><td rowspan=1 colspan=1>Between-day CV %</td><td rowspan=1 colspan=1>105</td><td rowspan=1 colspan=1>07</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>F07</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>40.6</td><td rowspan=1 colspan=1>5001</td><td rowspan=1 colspan=1>FOKG</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>057</td><td rowspan=1 colspan=1>1115</td><td rowspan=1 colspan=1>03</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>E0:53</td><td rowspan=1 colspan=1>07</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>13174</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>40'5</td></tr><tr><td rowspan=1 colspan=1>Within-dovice.CV.%</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>5156:</td><td rowspan=1 colspan=1>1912:</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>"4'0</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>51:57</td><td rowspan=1 colspan=1>B1:9</td><td rowspan=1 colspan=1>347</td><td rowspan=1 colspan=1>K47</td><td rowspan=1 colspan=1>E17</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>E16</td><td rowspan=1 colspan=1>317</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>398</td><td rowspan=1 colspan=1>316</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>3116</td><td rowspan=1 colspan=1>39</td><td rowspan=1 colspan=1>216</td><td rowspan=1 colspan=1>316</td><td rowspan=1 colspan=1></td></tr></table>

<table><tr><td>Munich</td><td>LocalTest System</td><td>Pi Molt Oalbrdo/ht d7501</td><td>P3636ao 05694</td></tr><tr><td></td><td>InnoWin lot 536967 Thromborel&#x27;S lot 545116 CPP3C2ANPP</td><td>Innovin 1ot 536967 Thromborel $ lot 545116</td><td>Innoviloti536967 Thromborel&#x27;S fot 5451.16</td></tr><tr><td>Mean (NR)</td><td>CPPEC23 NPP PPP RRP 1231328:21013:41 125:3.73/1:5 (3:4)</td><td>CPPI EC2NPPPPP CRR KC2 NPR PPP 21232911:013.6 249 $3.51 1015339</td><td>CRPJ HC2INPEPPP CPP C23 NPR R 2:21:2:91 Bou $3.61 13.2</td></tr><tr><td>Repeatability %</td><td>2123 10.5120.511051£3.7 [06 [0.9 10.6</td><td>131 10.670:517051 3.7 0.6 115170.6</td><td>12340.6[0.5[0.5 3.6150.61 1:01 0.6</td></tr><tr><td>Within-day-CV %</td><td>1.83 10.7210.7[0.81 [5:0::4114 3.0</td><td>1911071108:10.88 35.01 41 51:513:02</td><td>1.9110.7:10.8[0.81 E4:9R 41.57 13.0$</td></tr><tr><td>Between-run-CV %</td><td>131105 10.61 10&#x27;61 £3:3 14:0: 51:1 (3:0</td><td>1241505540.610.61 $3:31 463 511(3.0!</td><td>14:404910.611061 83:31£3.91 M151 2.9</td></tr><tr><td>Between-day CV % Within-device-CV %</td><td>50:010.8 11112191 :0.0:[0.0 1.5:2.3. 1811|1312:0]5:0:(4.12:1]13:8</td><td>010110:91126191 [0.010.0 E1.5[2.3] 31!91 3121515152115.04:1 2.2 3.8</td><td>10.010.91!21 1910:0110:0 11:31 2:3 1911311:49214:9 4:0]*2:01[3.7</td></tr></table>

<table><tr><td>Marburg</td><td>Loca estiSystem</td><td>pr Mut Caibaanasa</td><td>Pak 3a3palog o 38585</td></tr><tr><td></td><td>Innovin lot&#x27;539126Thromborel&#x27;S1ot545248</td><td>Innown tot&#x27;539126 Thromborel.S&#x27;10 545248</td><td>Innovin iot539126: Thromborel&#x27;S 1ot.545248</td></tr><tr><td></td><td>CPPEC2NPPPRR CRP C2] NRP PPP.</td><td>CPREC2NPP(PRPCRR| C2NPPPRR</td><td>CPPC21NPP PRP CPP EC2) NPP PPP</td></tr><tr><td>Mean (INR)</td><td>[223:081013.81 271 :3.8 1.0 [3.31</td><td>2.1281[1:0 [3.61 F259 E3!5 110231</td><td>2.213:0 R1!O 1377 27 $3:91 M01 13:3</td></tr><tr><td>Repeatability %</td><td>M131[0.6110!731041473:0.5:10910.73</td><td>1:31207[707 (0.41 4.72 10!5:61.010&#x27;63</td><td>13107707[0:41145710511091107</td></tr><tr><td>Within-day-CV % Between-run-CV %</td><td>31:4 [0.9 075091 14:8:[1:4 11:0: 51:3</td><td>21141 [0:91 10:7 [091148 [141 21:0:613) 10151 10!7 [0:2 50:8110.811:3:60.31:1</td><td>$141020710:94:8117411!013</td></tr><tr><td>Between-day CV %</td><td>[0:41 10:7 20:03£0.81 5:01 £1:3) 0.5 E1 10.91 13110.6!£111213:[2.2 0.9: 10.3</td><td>1.213 (0.61.12 12:3:122 1:0 10:3</td><td>[0.507[0:01 0:8:11 131104111 10.81E313130.61[102312210110:4</td></tr><tr><td></td><td>Within-device-CV % 1:611:6:10.9:14 15:4: .2:7 14 1:3</td><td>1:81:6[0.951 455.3*2,6:814:13</td><td>1:681620.9:14155:412:721:4613</td></tr></table>

Sample legend:

<table><tr><td rowspan=1 colspan=1>CPP</td><td rowspan=1 colspan=1>Control Plasma P</td></tr><tr><td rowspan=1 colspan=1>C2</td><td rowspan=1 colspan=1>Ci-Trol 2</td></tr><tr><td rowspan=1 colspan=1>NPP</td><td rowspan=1 colspan=1>normal plasma pool</td></tr><tr><td rowspan=1 colspan=1>PPP</td><td rowspan=1 colspan=1>pathological plasma pool</td></tr></table>

- below lowest calibrator

Siemens Healthcare Diagnostics Inc.   
c/o Mr. Radames Riesgo   
Regulatory Affairs & Compliance Manager Glasgow Business Community (GBC)   
PO Box 6101 MS 514   
Newark, DE 19702

Re: k093848 Trade/Device Name: PT-Multi Calibrator Regulation Number: 21 CFR $\ S 8 6 4 . 5 4 2 5$ E Regulation Name: Multipurpose System for In Vitro Coagulation Studies Regulatory Class: Class II Product Code: GGN, JIS Dated: November 29, 2010 Received: November 30, 2010

Dear Mr. Riesgo:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class I (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796- 5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to   
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Maria M. Chan, Ph.D   
Director   
Division of Immunology and Hematology Devices   
Office of In Vitro Diagnostic Device Evaluation and Safety   
Center for Devices and Radiological Health

# Attachment 4

# Indications for Use Statement

510(k) Number (if known): k093848

Device Name: PT-Multi Calibrator

DEC 2 0 2010

# Indications for Use:

Intended Use: PT-Multi Calibrator is intended as a calibrator set for local PT/INR calibration and/or local verification of the INR system for plasma based procedures with designated Siemens thromboplastins Dade $\textcircled{8}$ Innovin $\textcircled{8}$ or Thrombore $\textcircled{8}$ S on the $B C S \textcircled {8 } /$ BCS $\textsuperscript { \textregistered }$ XP Systems.